© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Effects of thyroid status on expression of voltage-gated potassium channels in rat left ventricle
aDepartment of Circulation, Research Institute of Environmental Medicine, Nagoya University, Nagoya 464-8601, Japan
bDepartment of Endocrinology and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Nagoya 464-8601, Japan
* Corresponding author. Tel.: +81 (52) 789 3867; Fax: +81 (52) 789 3887; E-mail: kambe@riem.nagoya-u.ac.jp
Objective: Thyroid hormone modifies cardiac action potentials and outward potassium currents directly and indirectly e.g. through β-adrenergic signaling pathway. We thus examined the expression of six voltage-gated potassium channel 
-subunits in the rat left ventricle under hypo- and hyperthyroid status, and tested roles of β-adrenergic signaling pathway in their expressions under both status. Methods: Hypothyroidism and hyperthyroidism were induced by administration of methimazole (MMI) for 4 weeks and by injection of L-thyroxine (T4) to the MMI-treated rats for the last 7 days, respectively. To distinguish the effects of T4 and the β-adrenergic system, propranolol (Pro) was administered to the MMI-treated rats together with T4, and isoproterenol (Iso) was injected to MMI-treated rats for the last 7 days. The mRNA levels of Kv1.2, Kv1.4, Kv1.5, Kv2.1, Kv4.2 and Kv4.3 in the left ventricles were determined by ribonuclease protection assay. Results: MMI treatment induced hypothyroidism and resulted in a significant decrease in the mRNA levels of Kv1.5, Kv2.1 and Kv4.2 (19%, 77% and 61% of control value, respectively; n=6, p<0.05). T4 administration induced hyperthyroidism and cardiac hypertrophy, and it increased the Kv1.5 and Kv2.1 mRNA levels over the control value (212% and 140%, respectively; n=6, p<0.05). Kv4.2 mRNA level was restored to the control level by T4. In contrast, the Kv1.2 and Kv1.4 mRNA levels increased in hypothyroid rats (161% and 186% of control value, respectively; n=6, p<0.01) and decreased in hyperthyroid rats (14% and 33% of control value, respectively; n=6, p<0.01). The Kv4.3 mRNA level was not altered by thyroid status. Pro did not inhibit the T4-induced hypertrophy. Iso induced cardiac hypertrophy. Pro or Iso by itself did not alter Kv mRNA levels except for Kv1.2, the message of which was decreased by Iso. Conclusion: Thyroid hormone differentially regulates the expression of Kv1.4, Kv1.5, Kv2.1 and Kv4.2 mRNA levels in the rat left ventricle. This effect is not mediated through β-adrenergic signaling pathway. On the other hand, the reduction in Kv1.2 mRNA level was associated with cardiac hypertrophy induced by T4 or Iso.
KEYWORDS Adrenergic (ant)agonist; Gene expression; Hormones; Hypertrophy; K-channel; Rat
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Gassanov, F. Er, G. Michels, N. Zagidullin, M. C. Brandt, and U. C. Hoppe Divergent regulation of cardiac KCND3 potassium channel expression by the thyroid hormone receptors {alpha}1 and {beta}1 J. Physiol., March 15, 2009; 587(6): 1319 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hu, S. V. P. Jones, and W. H. Dillmann Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1448 - H1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Ortiga-Carvalho, K. Hashimoto, C. C. Pazos-Moura, D. Geenen, R. Cohen, R. M. Lang, and F. E. Wondisford Thyroid Hormone Resistance in the Heart: Role of the Thyroid Hormone Receptor {beta} Isoform Endocrinology, April 1, 2004; 145(4): 1625 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jia and K. Takimoto GATA and FOG2 transcription factors differentially regulate the promoter for Kv4.2 K+ channel gene in cardiac myocytes and PC12 cells Cardiovasc Res, November 1, 2003; 60(2): 278 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shimoni and X.-F. Liu Role of PKC in autocrine regulation of rat ventricular K+ currents by angiotensin and endothelin Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1168 - H1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Madeja, T. Leicher, P. Friederich, M. A. Punke, W. Haverkamp, U. Musshoff, G. Breithardt, and E.-J. Speckmann Molecular Site of Action of the Antiarrhythmic Drug Propafenone at the Voltage-Operated Potassium Channel Kv2.1 Mol. Pharmacol., March 1, 2003; 63(3): 547 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Bouter, S. Demolombe, A. Chambellan, C. Bellocq, F. Aimond, G. Toumaniantz, G. Lande, S. Siavoshian, I. Baro, A. L. Pond, et al. Microarray Analysis Reveals Complex Remodeling of Cardiac Ion Channel Expression With Altered Thyroid Status: Relation to Cellular and Integrated Electrophysiology Circ. Res., February 7, 2003; 92(2): 234 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nishiyama, D. N. Ishii, P. H. Backx, B. E. Pulford, B. R. Birks, and M. M. Tamkun Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4 Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1800 - H1807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. d’Amati, C. R. T. di Gioia, D. Mentuccia, D. Pistilli, L. Proietti-Pannunzi, F. Miraldi, P. Gallo, and F. S. Celi Increased Expression of Thyroid Hormone Receptor Isoforms in End-Stage Human Congestive Heart Failure J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2080 - 2084. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Kamiya, A. Nishiyama, K. Yasui, M. Hojo, M. C. Sanguinetti, and I. Kodama Short- and Long-Term Effects of Amiodarone on the Two Components of Cardiac Delayed Rectifier K+ Current Circulation, March 6, 2001; 103(9): 1317 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Gloss, S. U. Trost, W. F. Bluhm, E. A. Swanson, R. Clark, R. Winkfein, K. M. Janzen, W. Giles, O. Chassande, J. Samarut, et al. Cardiac Ion Channel Expression and Contractile Function in Mice with Deletion of Thyroid Hormone Receptor {{alpha}} or {beta} Endocrinology, February 1, 2001; 142(2): 544 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Wickenden, R. Kaprielian, X.-M. You, and P. H. Backx The thyroid hormone analog DITPA restores Ito in rats after myocardial infarction Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1105 - H1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pazos-Moura, E. D. Abel, M.-E. Boers, E. Moura, T. G. Hampton, J. Wang, J. P. Morgan, and F. E. Wondisford Cardiac Dysfunction Caused by Myocardium-Specific Expression of a Mutant Thyroid Hormone Receptor Circ. Res., March 31, 2000; 86(6): 700 - 706. [Abstract] [Full Text] [PDF]
|
|